acorda therapeutics
Posted on April 24, 2008, 6:16 pmby admin
best video: acorda therapeutics
Materials Corp. (BOOM), Rambus Inc. (RMBS), Acorda Therapeutics, Inc. (ACOR), Cameco Corp. (CCJ),
More video:
forced to strip at school
automated dockboards
dominion door company
holistic medicine ann arbor
wyoming kindergarten standards
art deco tarraleah
wilmington nc air show 2008
original 1964 airline guitar sale as jack white
service electric cable sparta
rube baby clothes
bangor pool phone number
trammel crow art lomenick
sample eagle scout court of honor invitation
geography at the movies
trip check or
http://www.businesswire.com/news/google/20080325005887/en
http://www.inmoneytoday.com/2008/02/22/analyst-initiations-prsp-mvo-and-brli/
http://biz.yahoo.com/bw/080409/20080409005120.html?.v=1
http://www.acorda.com/
http://finance.yahoo.com/q?s=ACOR
http://www.forbes.com/businesswire/feeds/businesswire/2008/04/03/businesswire20080403005302r1.html
http://burbsbiz.lohudblogs.com/2008/04/09/acorda-has-deal-with-danish-drugmaker/
http://selectmetrix.com/blogs/2008/03/small-company-rewards/
http://www.centredaily.com/business/technology/story/522215.html
http://www.edgar-online.com/brand/yahoo/search/?cik=1008848
http://www.freemedsandsolutions.com/2.html?m6:cat=%2FAcorda%20Therapeutics
http://www.acorda.com/pipeline_fampridine_sci1.asp
http://www.outsourcing-pharma.com/news/ng.asp?n=84783-cmc-icos-farmaceutici-formenti-florida-biologix-jr-scientific
http://burbsbiz.lohudblogs.com/2008/04/03/acorda-names-senior-vice-president/
http://www.medicinenet.com/guide.asp?s=rss&k=DailyHealth&a=88587
http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070108005764&newsLang=en
http://caps.fool.com/Ticker/ACOR.aspx
http://finance.yahoo.com/q?s=ACOR
http://www.foxbusiness.com/markets/industries/health-care/article/acorda-therapeutics-names-john-librie-senior-vice-president-sales-marketing_546837_10.html
http://conservativeelitetrading.blogspot.com/2008/02/what-day-for-acor.html
http://www.pharmaceutical-business-review.com/article_news.asp?guid=56061061-B075-45AC-86C7-5B9E943B3F27
http://www.zanaflexcapsules.com/
http://www.acorda.com/
http://www.piribo.com/publications/finance/acorda_therapeutics_swot_analysis.html
http://burbsbiz.lohudblogs.com/2008/04/03/acorda-names-senior-vice-president/
http://burbsbiz.lohudblogs.com/2008/02/07/acorda-to-report-earnings-a-week-early/
http://biz.yahoo.com/bw/080414/20080414005146.html?.v=1
http://finance.aol.com/quotes/acorda-therapeutics-inc/acor/nas?tabs=quotesandnews
http://www.acorda.com/pipeline_remyelination.asp
http://www.piribo.com/publications/deals_alliances/acorda_therapeutics_inc_deals_alliances_report.html
http://www.rttnews.com/sp/breakingnews.asp?date=04/09/2008&item=94
http://www.secinvestor.com/2008/02/28/Elan+Turnaround+Gains+Steam+ELN+BIIB.aspx
http://biz.yahoo.com/bw/080403/20080403005302.html?.v=1
http://www.acorda.com/pipeline_fampridine_sci1.asp
http://finance.yahoo.com/q?s=ACOR
http://www.bioportfolio.com/may_05/12_05_2005/Acorda_Therapeutics_announces.html
http://www.webmd.com/multiple-sclerosis/news/20080410/ms-patients-say-mobility-is-top-problem
http://mymsjournal.blogspot.com/2008/03/mobility-study-results.html
http://biz.yahoo.com/bw/080409/20080409005288.html?.v=1
http://www.streetinsider.com/New+Coverage/Baird+Starts+Acorda+Therapeutics+ACOR+at+Neutral/3388066.html
http://www.acorda.com/clinical.asp
http://www.researchandmarkets.com/reports/571702/premium_company_profile_acorda_therapeutics
http://www.eurekalert.org/pub_releases/2008-04/uom-mpa041708.php
http://www.biotechstocksblog.com/2008/02/13/wendesdays-top-biotech-medical-stocks/
http://www.centredaily.com/business/technology/story/514191.html
http://biz.yahoo.com/bw/080310/20080310005434.html?.v=1
http://www.fiercebiotech.com/tags/acorda-therapeutics
http://www.acorda.com/
http://www.businesswire.com/news/google/20080409005288/en
http://market-research.typepad.com/microbiological_test/2008/02/acorda-therapeu.html
http://biz.yahoo.com/bw/080423/20080423005283.html?.v=1
http://finance.yahoo.com/q/sa?s=ACOR
http://www.acorda.com/
http://www.advfn.com/company-news-NASDAQ/Acorda-Therapeutics-ACOR.html
http://www.foxbusiness.com/markets/industries/health-care/article/acorda-therapeutics-host-conference-report-quarter-2008-financial-results-5_575120_10.html
http://burbsbiz.lohudblogs.com/2008/02/14/acorda-underwriters-to-buy-shares/
http://www.medicalnewstoday.com/articles/104717.php
http://finance.google.com/finance?q=NASDAQ:ACOR
http://finance.google.com/finance?q=NASDAQ:ACOR
http://www.advfn.com/news_Acorda-Therapeutics-to-Host-Analyst-and-Investor-Day_16033325.html
Materials Corp. (BOOM), Rambus Inc. (RMBS), Acorda Therapeutics, Inc. (ACOR), Cameco Corp. (CCJ),
More video:
 |  |  |
 |
forced to strip at school
automated dockboards
dominion door company
holistic medicine ann arbor
wyoming kindergarten standards
art deco tarraleah
wilmington nc air show 2008
original 1964 airline guitar sale as jack white
service electric cable sparta
rube baby clothes
bangor pool phone number
trammel crow art lomenick
sample eagle scout court of honor invitation
geography at the movies
trip check or
The most popular links about acorda therapeutics (by google opininon):
Loss of Mobility Found to Impact Quality of Life and Emotional and ... - Business Wire press release
The surveys were sponsored by acorda therapeutics in collaboration with the National MS Society. *In this survey, mobility or difficulty walking was defined ...http://www.businesswire.com/news/google/20080325005887/en
Analyst initiations: PRSP, MVO and BRLI
Analyst initiations: PRSP, MVO and BRLI Posted by: in Stocks Money News Filed under: Analyst initiations MOST NOTEWORTHY: Properity Bancshares, MV Oil Trust and Bio-Reference Lab were today??s noteworthy initiations: B. Riley initiated Prosperityhttp://www.inmoneytoday.com/2008/02/22/analyst-initiations-prsp-mvo-and-brli/
Acorda Therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS Business Wire via Yahoo! Finance
HAWTHORNE, N.Y. & COPENHAGEN, Denmark----Acorda Therapeutics, Inc. and CMC ICOS Biologics. Inc. today announced that acorda has selected CMC ICOS as the contract manufacturer for GGF2, the lead molecule in Acorda's neuregulin program.http://biz.yahoo.com/bw/080409/20080409005120.html?.v=1
Acorda Therapeutics :: Focused on restoring neurological function...
Acorda therapeutics to Host Conference Call to Report First Quarter 2008 Financial Results on May 5, 2008. April 9, 2008. acorda therapeutics to Host ...var mb1=ManyBox.register'1',5,'wAeLwhNMAUkJ','','c122',19,'Stock quote for ACOR'http://www.acorda.com/
ACOR: Summary for ACORDA THERAPEUTICS - Yahoo! Finance
... detailed information on acorda therapeutics ACOR including quote performance, ... acorda therapeutics to Host Analyst and Investor Breakfast Business ...http://finance.yahoo.com/q?s=ACOR
Acorda Therapeutics Names John Librie Senior Vice President, Sales ...
... in greater detail in acorda Therapeutics' filings with the Securities and Exchange Commission. acorda therapeutics may not actually ...http://www.forbes.com/businesswire/feeds/businesswire/2008/04/03/businesswire20080403005302r1.html
Acorda has deal with Danish drugmaker - Business in the Burbs
Acorda therapeutics Inc. of Hawthorne said a Danish drug company will manufacture a key molecule in a substance that acorda is using in toxicology studies ...http://burbsbiz.lohudblogs.com/2008/04/09/acorda-has-deal-with-danish-drugmaker/
Small Company Rewards
One of the real draws of working at a smaller company is the opportunity to have direct access to management-level decisions.? As larger companies trim their payrolls, skilled employees will enter the candidate pool.? These candidates may find a smallehttp://selectmetrix.com/blogs/2008/03/small-company-rewards/
New York Biotechnology Association to Present ''Women in Biotechnology'' and ''Regulatory and Policy Affairs'' ... Centre Daily Times
New York Biotechnology Association NYBA, the voice of New York State's biotechnology industry, announced today that it will feature two new pre-conference workshops as part of its 17th Annual Meeting: Women in Biotechnology and the Regulatory and Policyhttp://www.centredaily.com/business/technology/story/522215.html
EDGAR ONLINE - ACORDA THERAPEUTICS INC - SEC FILINGS
ACORDA therapeutics INC: ACOR Nasdaq National Mkt ... 4, acorda therapeutics INC PANEM SANDRA PHD, 02/19/08 02/14/08 ...http://www.edgar-online.com/brand/yahoo/search/?cik=1008848
Acorda Therapeutics
Med Solutions, freemedsandsolutions, Drug Assistance, Patient Assistant Programs, Medicare Beneficiary, Free Medicine,Help for Seniors, Help for the Disabled, Children Medications ...http://www.freemedsandsolutions.com/2.html?m6:cat=%2FAcorda%20Therapeutics
Acorda :: Pipeline :: Clinical :: Fampridine - SR:SCI
... in SCI In 2004, acorda completed two Phase 3 clinical trials of Fampridine ... acorda recently completed a Phase 3 clinical study of ...http://www.acorda.com/pipeline_fampridine_sci1.asp
Contract manufacturing news in brief - OutSourcing-Pharma.com
Biotechnology firm acorda therapeutics and contract manufacturer CMC Icos Biologics have entered an agreement whereby the latter will produce GGF2, ...http://www.outsourcing-pharma.com/news/ng.asp?n=84783-cmc-icos-farmaceutici-formenti-florida-biologix-jr-scientific
Acorda names senior vice president
Acorda names senior vice president April 3 John Librie has been named senior vice president of sales and marketing at acorda therapeutics Inc., a biotechnology company based in Hawthorne. Librie, who has more than 25 years experience in the industry,http://burbsbiz.lohudblogs.com/2008/04/03/acorda-names-senior-vice-president/
MS Patients Say Mobility Is Top Problem MedicineNet.com
Title: MS Patients Say Mobility Is Top Problem Category: Health News Created: 4/11/2008 Last Editorial Review: 4/11/2008http://www.medicinenet.com/guide.asp?s=rss&k=DailyHealth&a=88587
Acorda Therapeutics Announces Completion of Zanaflex CapsulesTM ...
HAWTHORNE, NY--BUSINESS WIRE--Acorda Therapeutics, Inc.? Nasdaq: ACOR reported today that it has completed the previously.http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070108005764&newsLang=en
ACOR Research Acorda Therapeutics, Inc. Research
ACOR has been added to your watchlist. You can find it in the watchlist tab on your My CAPS page. ...http://caps.fool.com/Ticker/ACOR.aspx
ACOR: Summary for ACORDA THERAPEUTICS - Yahoo! Finance
Get detailed information on acorda therapeutics ACOR including quote performance, Real-Time ECN, technical chart analysis, key stats, insider ...http://finance.yahoo.com/q?s=ACOR
Acorda Therapeutics Names John Librie Senior Vice President, Sales ... - FOXBusiness
Acorda therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. ...http://www.foxbusiness.com/markets/industries/health-care/article/acorda-therapeutics-names-john-librie-senior-vice-president-sales-marketing_546837_10.html
What A Day For ACOR!
ACOR is taking a huge bounce from yesterdays sale off. We are near my target of 25.00 and with an intraday high of 24.23! That is 5% from my call at 22.95 and up total today nearly 13%!! New Analysts Ranking and Shares Offered for sale in the spotlighthttp://conservativeelitetrading.blogspot.com/2008/02/what-day-for-acor.html
Acorda and CMC Icos sign manufacturing agreement Pharmaceutical Business Review
Acorda therapeutics has selected CMC Icos Biologics as the contract manufacturer for GGF2, the lead molecule in the companys neuregulin program.http://www.pharmaceutical-business-review.com/article_news.asp?guid=56061061-B075-45AC-86C7-5B9E943B3F27
Zanaflex Capsules
Copyright acorda Therapeutics, Inc. 2006. All rights reserved. acorda therapeutics privacy policy terms of use.http://www.zanaflexcapsules.com/
Acorda Therapeutics :: Focused on restoring neurological function...
April 9, 2008: acorda therapeutics to Host Analyst and Investor Breakfast : April 9, 2008: acorda therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOShttp://www.acorda.com/
Acorda Therapeutics - SWOT Analysis
Acorda therapeutics - SWOT Analysis Strategic Report BUY NOW from Piribo.com - &16363 / 127 / &836493 - Currently 7317 Market Research Reports ...http://www.piribo.com/publications/finance/acorda_therapeutics_swot_analysis.html
Acorda names senior vice president - Business in the Burbs
John Librie has been named senior vice president of sales and marketing at acorda therapeutics Inc., a biotechnology company based in Hawthorne. ...http://burbsbiz.lohudblogs.com/2008/04/03/acorda-names-senior-vice-president/
Acorda to report earnings a week early
Acorda to report earnings a week early February 7 acorda therapeutics Inc. said today it will release financial results for the fourth quarter and the year on Monday, a week earlier than previously announced. The Hawthorne-based biotechnology companhttp://burbsbiz.lohudblogs.com/2008/02/07/acorda-to-report-earnings-a-week-early/
New York Biotechnology Association to Present ''Women in Biotechnology'' and ''Regulatory and Policy Affairs'' ... Business Wire via Yahoo! Finance
NEW YORK----New York Biotechnology Association , the voice of New York State's biotechnology industry, announced today that it will feature two new pre-conference workshops as part of its 17th Annual Meeting: Women in Biotechnology and the Regulatory andhttp://biz.yahoo.com/bw/080414/20080414005146.html?.v=1
ACOR: ACORDA THERAPEUTICS INC Stock Quote
Research acorda therapeutics INC historical prices, historical volume, splits and dividends.http://finance.aol.com/quotes/acorda-therapeutics-inc/acor/nas?tabs=quotesandnews
Acorda :: Pipeline :: Preclinical/R&D :: Remyelination
Acorda??s remyelination programs include two distinct therapeutic approaches to stimulate repair of the damaged ...http://www.acorda.com/pipeline_remyelination.asp
Acorda Therapeutics, Inc. -Deals & Alliances Report
Acorda Therapeutics, Inc. -Deals & Alliances Report BUY NOW from Piribo.com - &163300 / 604 / &8364442 - Currently 9384 Market Research ...http://www.piribo.com/publications/deals_alliances/acorda_therapeutics_inc_deals_alliances_report.html
Acorda Selects CMC ICOS As Contract Manufacturer For GGF2 ACOR - RTT News
4/9/2008 10:28:07 AM Wednesday, acorda Therapeutics, Inc. ACOR, a biotechnology company, announced the selection of CMC ICOS Biologics. ...http://www.rttnews.com/sp/breakingnews.asp?date=04/09/2008&item=94
Elan Turnaround Gains Steam ELN, BIIB
Elan Corporation NYSE: ELN is a pharmaceutical turnaround story that may soon get even better. The pharmaceutical company had a brush with bankruptcy in 2002 and reported a wider-than-expected loss of 405 million for 2007. However, the company sahttp://www.secinvestor.com/2008/02/28/Elan+Turnaround+Gains+Steam+ELN+BIIB.aspx
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing Business Wire via Yahoo! Finance
HAWTHORNE, N.Y.----Acorda Therapeutics, Inc. today announced that John Librie has been promoted to Senior Vice President, Sales and Marketing. Mr. Librie will continue to manage the sales and marketing efforts of Zanaflex Capsules? , as well as overseehttp://biz.yahoo.com/bw/080403/20080403005302.html?.v=1
Acorda :: Pipeline :: Clinical :: Fampridine - SR:SCI
In 2004, acorda completed two Phase 3 clinical trials of Fampridine-SR in ... privacy policy terms of use Copyright? 2004-2006 acorda therapeutics Inc. ...http://www.acorda.com/pipeline_fampridine_sci1.asp
ACOR: Summary for ACORDA THERAPEUTICS - Yahoo! Finance
Get detailed information on acorda therapeutics ACOR including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...http://finance.yahoo.com/q?s=ACOR
BioPortfolio News : Acorda Therapeutics announces agreement with FDA ...
BioPortfolio News - acorda therapeutics announces agreement with FDA on special protocol assessment for Phase III clinical trial of ...http://www.bioportfolio.com/may_05/12_05_2005/Acorda_Therapeutics_announces.html
MS Patients Say Mobility Is Top Problem - WebMD
The polls were conducted by Harris Interactive on behalf of acorda therapeutics Inc. and the National MS Society. "We didn&39t expect to see that people who ...http://www.webmd.com/multiple-sclerosis/news/20080410/ms-patients-say-mobility-is-top-problem
Mobility Study Results
I got an email from Berry PR. They notified me of the Mobility Study results and asked me to pass it along to each of you. : There were actually two studies done, one conducted by Harris Interactive on behalf of acorda Therapeutics, Inc. and the other bhttp://mymsjournal.blogspot.com/2008/03/mobility-study-results.html
Acorda Therapeutics to Host Analyst and Investor Breakfast Business Wire via Yahoo! Finance
HAWTHORNE, N.Y.----Acorda Therapeutics, Inc. today announced that it will host an analyst and investor breakfast on April 14, 2007, at the American Academy of Neurology annual meeting.http://biz.yahoo.com/bw/080409/20080409005288.html?.v=1
StreetInsider.com - Baird Starts Acorda Therapeutics ACOR at Neutral
Feb 21, 2008 ... acorda therapeutics is a commercial-stage, biopharmaceutical company engaged in the identification, development and commercialization of ...http://www.streetinsider.com/New+Coverage/Baird+Starts+Acorda+Therapeutics+ACOR+at+Neutral/3388066.html
Acorda :: Clinical Trials
Acorda's clinical trials are designed to evaluate the safety and efficacy of ... privacy policy terms of use Copyright? 2004-2006 acorda therapeutics Inc. ...http://www.acorda.com/clinical.asp
Premium Company Profile Acorda Therapeutics - Market Research ...
Introduction acorda therapeutics was established in March 1995 to develop therapies that restore neurological function to people with spinal ...http://www.researchandmarkets.com/reports/571702/premium_company_profile_acorda_therapeutics
Minnesota partnership advances potential MS therapy - EurekAlert press release
Early stage process development was also performed in collaboration with acorda Therapeutics. The Partnership facility subsequently developed production of ...http://www.eurekalert.org/pub_releases/2008-04/uom-mpa041708.php
Wendesday??s Top Biotech & Medical Stocks
Wendesday??s Top Biotech & Medical Stocks Posted in February 13th, 2008 by admin in Uncategorized Submitted by BioHealth Investor Blog by H.S. Ayoub BioHealth Investor Subscribe now to keep up to date on the latest news, articles and daily top shttp://www.biotechstocksblog.com/2008/02/13/wendesdays-top-biotech-medical-stocks/
Acorda Therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS Centre Daily Times
Acorda Therapeutics, Inc. NASDAQ: ACOR and CMC ICOS Biologics. Inc. today announced that acorda has selected CMC ICOS as the contract manufacturer for GGF2, the lead molecule in Acorda's neuregulin program. In preclinical studies, neuregulins have demonhttp://www.centredaily.com/business/technology/story/514191.html
Acorda Therapeutics to Present at the Cowen and Company 28th ...
Acorda therapeutics to Present at the Cowen and Company 28th Annual Health Care Conference. - HAWTHORNE, NY--BUSINESS WIRE--Acorda Therapeutics, ...http://biz.yahoo.com/bw/080310/20080310005434.html?.v=1
Acorda Therapeutics news - FierceBiotech
Read the latest acorda therapeutics news and developments from FierceBiotech. ... Cancer Valeant Pharmaceuticals acorda therapeutics schizophrenia drug Galenica ...http://www.fiercebiotech.com/tags/acorda-therapeutics
Acorda Therapeutics :: Focused on restoring neurological function...
Acorda therapeutics to Host Analyst and Investor Breakfast ... acorda therapeutics Signs GGF2 Manufacturing Agreement with CMC ICOS ...http://www.acorda.com/
Acorda Therapeutics to Host Analyst and Investor Breakfast - Business Wire press release
HAWTHORNE, NY--BUSINESS WIRE--Acorda Therapeutics, Inc. NASDAQ: ACOR today announced that it will host an analyst and investor breakfast on April 14, ...http://www.businesswire.com/news/google/20080409005288/en
Acorda Therapeutics, Inc. Announces Pricing of Public Offering of ... - News & Observer
acorda Therapeutics, Inc. Announces Pricing of Public Offering of ... News & Observer, NC - 1 hour ago acorda Therapeutics, Inc. is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system dihttp://market-research.typepad.com/microbiological_test/2008/02/acorda-therapeu.html
Acorda Therapeutics to Host Conference Call to Report First Quarter 2008 Financial Results on May 5, 2008 Business Wire via Yahoo! Finance
HAWTHORNE, N.Y.----Acorda Therapeutics, Inc. announced today that it will report its financial results for the first quarter of 2008 on Monday, May 5, 2008 at 8:30 a.m. ET before the U.S. financial markets open.http://biz.yahoo.com/bw/080423/20080423005283.html?.v=1
ACOR: Star Analysts for ACORDA THERAPEUTICS - Yahoo! Finance
Get detailed information on acorda therapeutics ACOR including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions ...http://finance.yahoo.com/q/sa?s=ACOR
Acorda Therapeutics :: Focused on restoring neurological function...
Develops therapeutic products for spinal cord injury and other central nervous system disorders.http://www.acorda.com/
Acorda Therapeutics Stock News ACOR Announcements Reports & Results
Acorda therapeutics ACOR company news, announcements, releases, reports results & notices...http://www.advfn.com/company-news-NASDAQ/Acorda-Therapeutics-ACOR.html
Acorda Therapeutics to Host Conference Call to Report First ... - FOXBusiness
HAWTHORNE, NY, Apr 23, 2008 BUSINESS WIRE -- acorda Therapeutics, Inc. NASDAQ: ACOR announced today that it will report its financial results for the ...Cytori therapeutics to Webcast 1st Quarter Results on May 9, 2008 PR-Inside.com Pressemitteilunghttp://www.foxbusiness.com/markets/industries/health-care/article/acorda-therapeutics-host-conference-report-quarter-2008-financial-results-5_575120_10.html
Acorda underwriters to buy shares
Acorda underwriters to buy shares February 14 acorda therapeutics Inc., the Hawthorne biotechnology company, said this morning the underwriters of its upcoming stock offering have exercised their option to buy an additional 495,000 shares. That bringhttp://burbsbiz.lohudblogs.com/2008/02/14/acorda-underwriters-to-buy-shares/
Potential MS Therapy Advanced By Minnesota Partnership Medical News Today
A production laboratory founded by the Minnesota Partnership has transferred its first potential therapy - a medication for multiple sclerosis - to a processing plant in Minnesota. This step will complete purification of material to fully enable translatihttp://www.medicalnewstoday.com/articles/104717.php
ACOR - Acorda Therapeutics Inc. - Google Finance
Get the latest on acorda therapeutics Inc. ACOR including stock quotes, interactive charts, up to date news, high quality discussion groups and more on ...http://finance.google.com/finance?q=NASDAQ:ACOR
ACOR - Acorda Therapeutics Inc. - Google Finance
Get the latest on acorda therapeutics Inc. ACOR including stock quotes, interactive charts, up to date news, high quality discussion groups and more on Google Finance.http://finance.google.com/finance?q=NASDAQ:ACOR
Acorda Therapeutics to Host Analyst and Investor Day
ACOR acorda therapeutics acorda therapeutics to Host Analyst and Investor Day...http://www.advfn.com/news_Acorda-Therapeutics-to-Host-Analyst-and-Investor-Day_16033325.html